Aspira Women’s Health

Aspira Women’s Health appoints Ellen Beausang to Board of Directors

Aspira Women’s Health Appoints Dr. Sandra Milligan as Interim CEO Following Departure of Nicole Sandford

Aspira Women’s Health and BioReference® expand collaboration to launch OvaWatch

Aspira Women’s Health to provide $1.935 Million private placement equity financing

Revolutionizing Women’s Gynecological Health: The Aspira Women’s Health Story